2,378
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

Alterations in the gut virome are associated with type 2 diabetes and diabetic nephropathy

ORCID Icon, , , , , , , , , , , , , , , , , , , , , & show all
Article: 2226925 | Received 05 Mar 2023, Accepted 14 Jun 2023, Published online: 22 Jun 2023

References

  • Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–17. doi:10.1038/nrendo.2017.151.
  • Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019;62(1):3–16. doi:10.1007/s00125-018-4711-2.
  • Selby NM, Taal MW. An updated overview of diabetic nephropathy: diagnosis, prognosis, treatment goals and latest guidelines. Diabetes Obes Metab. 2020;22(S1):3–15. doi:10.1111/dom.14007.
  • Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol. 2021;19(1):55–71. doi:10.1038/s41579-020-0433-9.
  • Reyes A, Haynes M, Hanson N, Angly FE, Heath AC, Rohwer F, Gordon JI. Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature. 2010;466(7304):334–338. doi:10.1038/nature09199.
  • Rasmussen TS, Koefoed AK, Jakobsen RR, Deng L, Castro-Mejía JL, Brunse A, Neve H, Vogensen FK, Nielsen DS. Bacteriophage-mediated manipulation of the gut microbiome – promises and presents limitations. FEMS Microbiol Rev. 2020;44(4):507–521. doi:10.1093/femsre/fuaa020.
  • Lang S, Demir M, Martin A, Jiang L, Zhang XL, Duan Y, Gao B, Wisplinghoff H, Kasper P, Roderburg C, et al. Intestinal virome signature associated with severity of nonalcoholic fatty liver disease. Gastroenterology. 2020;159(5):1839–1852. doi:10.1053/j.gastro.2020.07.005.
  • Nakatsu G, Zhou HK, Wu KK, Wong SH, Coker OO, Dai ZW, Li XC, Szeto CH, Sugimura N, Lam TY, et al. Alterations in enteric virome are associated with colorectal cancer and survival outcomes. Gastroenterology. 2018;155(2):529. doi:10.1053/j.gastro.2018.04.018.
  • Jiang L, Lang SJ, Duan Y, Zhang XL, Gao B, Chopyk J, Schwanemann LK, Ventura-Cots M, Bataller R, Bosques-Padilla F, et al. Intestinal virome in patients with alcoholic hepatitis. Hepatology. 2020;72(6):2182–2196. doi:10.1002/hep.31459.
  • Norman JM, Handley SA, Baldridge MT, Droit L, Liu CY, Keller BC, Kambal A, Monaco CL, Zhao GY, Fleshner P, et al. Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell. 2015;160(3):447–460. doi:10.1016/j.cell.2015.01.002.
  • Clooney AG, Sutton TDS, Shkoporov AN, Holohan RK, Daly KM, O’Regan O, Ryan FJ, Draper LA, Plevy SE, Ross RP, et al. Whole-virome analysis sheds light on viral dark matter in inflammatory bowel disease. Cell Host & Microbe. 2019;26(6):764. doi:10.1016/j.chom.2019.10.009.
  • Ma YF, You XY, Mai GQ, Tokuyasu T, Liu CL. A human gut phage catalog correlates the gut phageome with type 2 diabetes. Microbiome. 2018;6(1):6. doi:10.1186/s40168-018-0410-y.
  • Rasmussen TS, Mentzel CMJ, Kot W, Castro-Mejía JL, Zuffa S, Swann JR, Hansen LH, Vogensen FK, Hansen AK, Nielsen DS. Faecal virome transplantation decreases symptoms of type 2 diabetes and obesity in a murine model. Gut. 2020;69(12):2122–2130. doi:10.1136/gutjnl-2019-320005.
  • Yang KL, Niu JK, Zuo T, Sun Y, Xu ZL, Tang W, Liu Q, Zhang JW, Enders KW, Wong S, et al. Alterations in the gut virome in obesity and type 2 diabetes mellitus. Gastroenterology. 2021;161(4):1257. doi:10.1053/j.gastro.2021.06.056.
  • Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7(5):335–336. doi:10.1038/nmeth.f.303.
  • Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13(7):581. doi:10.1038/Nmeth.3869.
  • Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol. 2007;73(16):5261–5267. doi:10.1128/AEM.00062-07.
  • Thukral AK. A review on measurement of Alpha diversity in biology. Intern J Contemp Microbiol. 2007;54(1):1. doi:10.5958/2395-146X.2017.00001.1.
  • Pelissier R, Couteron P, Dray S. Analyzing or explaining beta diversity? Comment Ecology. 2008;89(11):3232–3237. doi:10.1890/08-1247.1.
  • Zuo T, Lu XJ, Zhang Y, Cheung CP, Lam S, Zhang F, Tang W, Ching JYL, Zhao R, Chan PKS, et al. Gut mucosal virome alterations in ulcerative colitis. Gut. 2019;68(7):1169. doi:10.1136/gutjnl-2018-318131.
  • Kong C, Liu G, Kalady MF, Jin T, Ma Y. Dysbiosis of the stool DNA and RNA virome in Crohn’s disease. J Med Virol. 2023;95(2):e28573. doi:10.1002/jmv.28573.
  • Qin JJ, Li YR, Cai ZM, Li SH, Zhang JF, Zhang F, Liang SS, Zhang WW, Guan YL, Shen DQ, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490(7418):55–60. doi:10.1038/nature11450.
  • Cao ZR, Sugimura N, Burgermeister E, Ebert MP, Zuo T, Lan P. The gut virome: a new microbiome component in health and disease. Ebiomedicine. 2022;81:81. doi:10.1016/j.ebiom.2022.104113.
  • Liang G, Bushman FD. The human virome: assembly, composition and host interactions. Nat Rev Microbiol. 2021;19(8):514–527. doi:10.1038/s41579-021-00536-5.
  • De Jonge PA, Wortelboer K, Scheithauer TPM, van den Born BJH, Zwinderman AH, Nobrega FL, Dutilh BE, Nieuwdorp M, Herrema H. Gut virome profiling identifies a widespread bacteriophage family associated with metabolic syndrome. Nat Commun. 2022;13(1):13. doi:10.1038/s41467-022-31390-5.
  • Popescu M, Van Belleghem JD, Khosravi A, Bollyky PL. Bacteriophages and the immune system. Annu Rev Virol. 2021;8(1):415–435. doi:10.1146/annurev-virology-091919-074551.
  • Gogokhia L, Buhrke K, Bell R, Hoffman B, Brown G, Hanke-Gogokhia C, Ajami N, Wonge MC, Ghazaryan A, JF V, et al. Expansion of bacteriophages is linked to aggravated intestinal inflammation and colitis. Cell Host & Microbe. 2019;25(2):285–299.e8. doi:10.1016/j.chom.2019.01.008.
  • Du L, Li Q, Yi H, Kuang T, Tang Y, Fan G. Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitus. Biomed Pharmacother. 2022;149:112839. doi:10.1016/j.biopha.2022.112839.
  • Chan H, Li Q, Wang XS, Liu WY, Hu W, Zeng JD, Xie C, Kwong TNY, IHT H, Liu XD, et al. Vitamin D3 and carbamazepine protect against Clostridioides difficile infection in mice by restoring macrophage lysosome acidification. Autophagy. 2022;18(9):2050–2067. doi:10.1080/15548627.2021.2016004.
  • Nagata E, Oho T. Invasive Streptococcus mutans induces inflammatory cytokine production in human aortic endothelial cells via regulation of intracellular toll-like receptor 2 and nucleotide-binding oligomerization domain 2. Mol Oral Microbiol. 2016;32(2):131. doi:10.1111/omi.12159.
  • Naka S, Nomura R, Takashima Y, Okawa R, Ooshima T, Nakano K. A specific Streptococcus mutans strain aggravates non-alcoholic fatty liver disease. Oral Dis. 2014;20(7):700–706. doi:10.1111/odi.12191.
  • Du X, Liu J, Xue Y, Kong XY, Lv CX, Li ZQ, Huang YH, Wang BH. Alteration of gut microbial profile in patients with diabetic nephropathy. Endocrine. 2021;73(1):71–84. doi:10.1007/s12020-021-02721-1.
  • Tao SB, Li LZ, Ma L, Fu P. Understanding the gut-kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition. Nephrol Dial Transpl. 2019;34(Supplement_1):216. doi:10.1007/s00592-019-01316-7.
  • Desai MS, Seekatz AM, Koropatkin NM, Kamada N, Hickey CA, Wolter M, Pudlo NA, Kitamoto S, Terrapon N, Muller A, et al. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell. 2016;167(5):1339. doi:10.1016/j.cell.2016.10.043.
  • Saito Y, Sato T, Nomoto K, Tsuji H. Identification of phenol- and p-cresol-producing intestinal bacteria by using media supplemented with tyrosine and its metabolites. FEMS Microbiol Ecol. 2020;96. doi:10.1093/femsec/fiy125.
  • Pletinck A, Vanholder R, Glorieux G. Uremic toxins. Hoboken, N.J: John Wiley & Sons; 2012.
  • Gregory AC, Zablocki O, Zayed AA, Howell A, Sullivan MB, Sullivan, M B. The gut virome database reveals age-dependent patterns of virome diversity in the human gut. Cell Host & Microbe. 2020;28(5):724–740.e8. doi:10.1016/j.chom.2020.08.003.
  • Nishijima S, Nagata N, Kiguchi Y, Kojima Y, Miyoshi-Akiyama T, Kimura M, Ohsugi M, Ueki K, Oka S, Mizokami M, et al. Extensive gut virome variation and its associations with host and environmental factors in a population-level cohort. Nat Commun. 2022;13(1):5252. doi:10.1038/s41467-022-32832-w.
  • Minot S, Sinha R, Chen J, Li H, Keilbaugh SA, Wu GD, Lewis JD, Bushman FD. The human gut virome: inter-individual variation and dynamic response to diet. Genome Res. 2011;21(10):1616–1625. doi:10.1101/gr.122705.111.
  • Zuo T, Sun Y, Wan YT, Yeoh YK, Zhang F, Cheung CP, Chen N, Luo J, Wang W, Sung JJY, et al. Human-gut-DNA virome variations across geography, ethnicity, and urbanization. Cell Host & Microbe. 2020;28(5):741–751.e4. doi:10.1016/j.chom.2020.08.005.
  • Volkova A, Ruggles KV. Predictive metagenomic analysis of autoimmune disease identifies robust autoimmunity and disease specific microbial signatures. Front Microbiol. 2021;12:12. doi:10.3389/fmicb.2021.621310.
  • Wang XW, Liu YY. Comparative study of classifiers for human microbiome data. Med Microecol. 2020;4:4. doi:10.1016/j.medmic.2020.100013.
  • Yassour M, Lim MY, Yun HS, Tickle TL, Sung J, Song YM, Lee K, Franzosa EA, Morgan XC, Gevers D, et al. Sub-clinical detection of gut microbial biomarkers of obesity and type 2 diabetes. Genome Med. 2016;8(1). doi:10.1186/s13073-016-0271-6.
  • Young BA, Lin E, Von Korff M, Simon G, Ciechanowski P, Ludman EJ, Everson-Stewart S, Kinder L, Oliver M, Boyko EJ, et al. Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization. Am J Manag Care. 2008;14:15–23.